Investigation summary: based on the information available, there was no device available for analysis and there was no report of a device performance allegation during treatment.The reported patient symptoms are a known risk associated with water vapor therapy procedure and are noted as such in the device instructions for use.Device history record (dhr): a dhr and ship history review cannot be performed as the lot number was not available.Device technical analysis: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Labeling review: the delivery device instructions for use (ifu) was reviewed.The patient symptoms of hematuria, anejaculation, pain were found to be listed in the ifu.Investigation conclusion: based on the information available, a conclusion code of known inherit risk of device was assigned to this investigation.
|
It was reported that post a water vapor therapy procedure, the patient experienced irritative symptoms, blood in urine and was unable to ejaculate.The blood in the patient's urine resolved six days post procedure; however, the patient then developed urinary retention a few days after.The patient was catheterized.After removing the catheter, the patient was able to urinate in small amounts; however, experienced burning sensation when urinating.The patient also had lower abdominal pain after orgasms.After beginning medication to treat the patient's symptoms, the patient visited the emergency room (er) for side effects developed from the medication.The patient is now doing okay but is unable to ejaculate.After the patient's last visit to the er, the patient no longer experience tenderness in his prostate and other symptoms but is still not able to ejaculate.
|